This statistic describes the operating profit after taxation of GlaxoSmithKline from 2006 to 2017. In 2017, the company reported a profit after taxation of approximately 2.2 billion British pounds. GlaxoSmithKline plc is a global pharmaceutical and biotech company, headquartered in London. GSK is a pharmaceutical company with focus on products fighting respiratory diseases and HIV (via the ViiV Healthcare joint venture with Pfizer).
GlaxoSmithKline's profit from 2006 to 2017 (in million British pounds)*
Exclusive Premium Statistic
This statistic describes the operating profit after taxation of GlaxoSmithKline from 2006 to 2017. In 2017, the company reported a profit after taxation of approximately 2.2 billion British pounds. GlaxoSmithKline plc is a global pharmaceutical and biotech company, headquartered in London. GSK is a pharmaceutical company with focus on products fighting respiratory diseases and HIV (via the ViiV Healthcare joint venture with Pfizer).
More information
Statista Accounts: Access All Statistics. Starting from $588 / Year
Statistics on "Pharmaceutical trends in Europe"
Statista for Your Company: The Research and Analysis Tool
Further Content: Statistics, Studies, and Topic Pages
Statistics
- GlaxoSmithKline's revenue 2006-2017
- GlaxoSmithKline's revenue by region 2013-2017
- GlaxoSmithKline's revenue by division 2006-2017
- GlaxoSmithKline's number of employees by region 2011-2017
- GlaxoSmithKline: expenditure on research and development 2006-2017
- GlaxoSmithKline's operating profit by division 2006-2017
- GlaxoSmithKline's expenditure on research and development by sector 2015-2017
- GlaxoSmithKline: cash flow 2006-2017
- Americans on US pharma quality compared to foreign pharma 2017, by gender
- Veterinary vaccines market share worldwide in 2016, by technology
- Americans' rating of diversity of products in the pharma industry by gender 2017
- US adults who believe their doctor is up-to-date on new drugs by age 2017
- Pharmaceutical expenditure forecast worldwide by country 2030
- US adults impression of the US pharma industry self-regulation, by gender 2017
- Abbott Laboratories' profit 2006-2017
- Top rare disease therapeutic companies enterprise value worldwide 2000-2017
- Pricing of orphan drugs across three countries on annual basis 2016
- Percentage savings through generic drug usage in the U.S. by payor 2016
- Expected consequences of moving US pharma manufacturing to the US